Locations
Indianapolis, IN, USA
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Series B
founded in
2017
Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics, enabling medical practitioners to advance healing through microbiome therapeutics.
Something looks off?